These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10789960)

  • 21. A prospective, randomized study comparing cefozopran with piperacillin-tazobactam plus ceftazidime as empirical therapy for febrile neutropenia in children with hematological disorders.
    Sato T; Kobayashi R; Yasuda K; Kaneda M; Iguchi A; Kobayashi K
    Pediatr Blood Cancer; 2008 Dec; 51(6):774-7. PubMed ID: 18661495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous infusion of ceftazidime in the empiric treatment of febrile neutropenic children with cancer.
    Dalle JH; Gnansounou M; Husson MO; Lambilliotte A; Mazingue F; Nelken B
    J Pediatr Hematol Oncol; 2002 Dec; 24(9):714-6. PubMed ID: 12468910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of cefepime and ceftazidime in combination with amikacin in the empirical treatment of high-risk patients with febrile neutropenia: a prospective, randomized, multicenter study.
    Erman M; Akova M; Akan H; Korten V; Ferhanoğlu B; Köksal I; Cetinkaya Y; Uzun O; Unal S;
    Scand J Infect Dis; 2001; 33(11):827-31. PubMed ID: 11760163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ceftazidime in combination with glycopeptide antibiotic is an effective first-line therapy for patients undergoing high-dose therapy with autologous peripheral blood stem cell support.
    Egerer G; Goldschmidt H; Streich N; Ehrhard I; Sonntag HG; Haas R
    Support Care Cancer; 1999 Sep; 7(5):336-42. PubMed ID: 10483819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of meropenem with ceftazidime as monotherapy of cancer patients with chemotherapy induced febrile neutropenia.
    Malik I; Shaharyar
    J Pak Med Assoc; 2002 Jan; 52(1):15-8. PubMed ID: 11963577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-step empiric treatment for severely neutropenic patients with fever: ceftazidime--vancomycin--amphotericin B.
    Koeppler H; Pflueger KH; Seitz R; Havemann K
    Infection; 1989; 17(3):142-5. PubMed ID: 2661438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients. The Meropenem Study Group of Leuven, London and Nijmegen.
    J Antimicrob Chemother; 1995 Jul; 36(1):185-200. PubMed ID: 8537265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Empiric monotherapy for febrile neutropenia--a randomized study comparing meropenem with ceftazidime.
    Lindblad R; Rödjer S; Adriansson M; Andreasson B; Bäckström B; Johansson P; Karlsson K; Rhedin C; Turesson I
    Scand J Infect Dis; 1998; 30(3):237-43. PubMed ID: 9790130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem.
    Freifeld AG; Walsh T; Marshall D; Gress J; Steinberg SM; Hathorn J; Rubin M; Jarosinski P; Gill V; Young RC
    J Clin Oncol; 1995 Jan; 13(1):165-76. PubMed ID: 7799016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Penicillin or vancomycin plus ceftazidime in febrile neutropenic patients after stem cell transplantation.
    Kargar Samani K; Vandercam B; Straetmans N; Michaux L; Ferrant A
    Acta Clin Belg; 2000; 55(5):279-84. PubMed ID: 11109643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of treatment pathways in outpatient treatment of low risk febrile neutropenic cancer patients.
    Escalante CP; Weiser MA; Manzullo E; Benjamin R; Rivera E; Lam T; Ho V; Valdres R; Lee EL; Badrina N; Fernandez S; DeJesus Y; Rolston K
    Support Care Cancer; 2004 Sep; 12(9):657-62. PubMed ID: 15185134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review.
    Lorente L; Jiménez A; Palmero S; Jiménez JJ; Iribarren JL; Santana M; Martín MM; Mora ML
    Clin Ther; 2007 Nov; 29(11):2433-9. PubMed ID: 18158083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.
    Cordonnier C; Herbrecht R; Pico JL; Gardembas M; Delmer A; Delain M; Moreau P; Ladeb S; Nalet V; Rollin C; Gres JJ
    Clin Infect Dis; 1997 Jan; 24(1):41-51. PubMed ID: 8994754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study.
    de la Cámara R; Figuera A; Sureda A; Hermida G; Verge G; Olalla I; Fernández Rañada JM; Domingo Albos A
    Haematologica; 1997; 82(6):668-75. PubMed ID: 9580087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
    Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks JE; Gill V; Steinberg SM; Pizzo PA
    N Engl J Med; 1999 Jul; 341(5):305-11. PubMed ID: 10423464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empirical therapy for neutropenic fever in children with malignancy.
    Hung KC; Chiu HH; Tseng YC; Wang JH; Lin HC; Tsai FJ; Peng CT
    J Microbiol Immunol Infect; 2003 Dec; 36(4):254-9. PubMed ID: 14723254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients.
    Flaherty JP; Waitley D; Edlin B; George D; Arnow P; O'Keefe P; Weinstein RA
    Am J Med; 1989 Nov; 87(5A):278S-282S. PubMed ID: 2686429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey.
    Agaoglu L; Devecioglu O; Anak S; Karakas Z; Yalman N; Biner B; Eryilmaz E; Goksan B; Unuvar A; Agirbasli H; Can M; Bilgen H; Gedikoglu G
    J Chemother; 2001 Jun; 13(3):281-7. PubMed ID: 11450887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study of cefepime versus ceftazidime as empiric therapy of febrile episodes in neutropenic patients.
    Wang FD; Liu CY; Hsu HC; Gau JP; Chau WK; Haung ML; Ho CH
    Chemotherapy; 1999; 45(5):370-9. PubMed ID: 10473925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia.
    Montalar J; Segura A; Bosch C; Galan A; Juan O; Molins C; Giner V; Aparicio J
    Med Oncol; 2002; 19(3):161-6. PubMed ID: 12482126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.